Boothbay Fund Management, LLC Y M Abs Therapeutics, Inc. Transaction History
Boothbay Fund Management, LLC
- $3.28 Billion
- Q1 2025
A detailed history of Boothbay Fund Management, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 693,693 shares of YMAB stock, worth $3.19 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
693,693
Previous 693,693
-0.0%
Holding current value
$3.19 Million
Previous $5.43 Million
43.42%
% of portfolio
0.09%
Previous 0.17%
Shares
9 transactions
Others Institutions Holding YMAB
# of Institutions
105Shares Held
27.1MCall Options Held
38.4KPut Options Held
2.1K-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$19.5 Million0.96% of portfolio
-
Acorn Capital Advisors, LLC New York, NY3.24MShares$14.9 Million9.97% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$13.5 Million0.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$10.1 Million0.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$8.95 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $201M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...